Have You Been Diagnosed With Bipolar Disorder and Experiencing Symptoms of Depression?
Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Lindner Center of HOPE
Location: 4075 Old Western Row Road, Mason, OH
Lead Researcher: Dr. Susan McElroy
Ethics Committee: This material has been reviewed and approved by the University of Cincinnati Institutional Review Board
Bipolar Disorder, also referred to as manic-depressive disorder, affects 2-3% of Americans. To date there is no exact way to distinguish between the most common causes of depression which include bipolar I, bipolar II, and major depressive disorder. Finding a way to accurately determine the cause will help those diagnosed to receive a more effective treatment.
Researchers are looking to understand if proteins in the bloodstream, measured with a blood test, can determine if a depressed person has bipolar I disorder, bipolar II disorder, or major depressive disorder.
This study seeks men and women between the ages of 18 and 70 who have been diagnosed with bipolar type I or II disorder and are currently experiencing symptoms of depression. Participants are required to attend 6 study site visits over 2 months and will be compensated up to $350 upon completion of the study.
Benefits to Participation
- You will be compensated up to $350 for participating in the study
- You will be helping to improve treatment accuracy and options for those with depression and bipolar disorder
- You will be helping to advance medical research.
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women between the ages of 18 and 70 years old.
- Have been diagnosed with bipolar type I or II disorder and are currently experiencing symptoms of depression.
- Able to attend 6 visits at the study site in Mason, Ohio within a period of approximately 2 months.